本公司及董事会全体成员保证公告的内容真实、准确、完整，没有虚假记 载、误导性陈述或重大遗漏。 特别提示： 1、本次股东大会无新增、变更、否决提案的情况； 2、本次股东大会不涉及变更前次股东大会的决议； 3、本次股东大会以现场投票和网络投票相结合的方式召开； 4、为尊重中小投资者利益，提高中小投资者对本次股东大会决议事项的参 与度，本次股东大会对审议影响中小投资者利益的重大事项进行单独计票。中小 投资者是指除上市公司董事、监事、高级管理人员以及单独或者合计持有公司 5%以上股份的股东以外的其他股东。 一、会议召开和出席情况 证券代码：300451 证券简称：创业慧康 公告编号：2025-057 创业慧康科技股份有限公司 2025年第一次临时股东大会决议公告 （一）会议召开情况 1、召开时间： （1）现场会议日期和时间：2025 年 10 月 15 日（星期三）下午 14:30 （2）网络投票日期和时间：2025 年 10 月 15 日。其中，通过深圳证券交易 所交易系统进行网络投票的具体时间为：2025年10月15日9:15-9:25、9:30-11:30， 13:00-15:00。通过深圳证券交易所互联网投票 ...

Summary of Key Points Core Viewpoint - Several companies are experiencing significant shareholder reductions, with multiple stakeholders planning to decrease their holdings by various percentages, indicating potential shifts in investor confidence and market dynamics [1]. Shareholder Reductions - Watson Pharmaceutical's controlling shareholder plans to reduce holdings by up to 3% [1] - Tianli Lithium Energy's New Materials Fund intends to reduce holdings by up to 3% [1] - Guangkang Biochemical's shareholder Ruihong Kaiyin No.1 plans to reduce holdings by up to 2.6757% [1] - Huayi Technology's shareholder Huang Daqing aims to reduce holdings by no more than 3% [1] - Magu Technology's shareholder Xu Longxiang plans to reduce holdings by up to 0.86% [1] - Saiwu Technology's shareholders Suzhou Suyu and Suzhou Saiying plan to collectively reduce holdings by 1.32% [1] - New Xunda's Minmetals International Trust has cumulatively reduced holdings by 1% [1] - Yandong Micro's Jingguorui has cumulatively reduced 1% of company shares [1] - Aohua Endoscopy's shareholders Junlian Xinkang and Gao Shen have cumulatively reduced 1.92% of shares [1] - Zhejiang Natural's Tiantai Ruiju Equity Investment Center has completed a 1% reduction in company shares [1] - Chunzong Technology's He Shida has cumulatively reduced 2 million shares [1] - Chiao Sensor's Li Hongqing has reduced 16 million shares through block trading [1] - Chuangye Huikang's Philips has cumulatively reduced 1.0195% of shares [1] Other Notable Events - Ruyi Group is under investigation by the China Securities Regulatory Commission for suspected information disclosure violations [1] - Huangting International has terminated plans for significant asset sales and debt restructuring [1]

格隆汇10月14日丨创业慧康(300451.SZ)公布，近日收到飞利浦（中国）投资有限公司（简称"飞利浦"） 出具的《告知函》，飞利浦已通过集中竞价及大宗交易方式合计减持公司股份15,793,764股，占公司总 股本1.019528%（占剔除公司回购专用账户股份后的总股本比例为1.022630%）。 ...

每经AI快讯，10月14日，创业慧康（300451）(300451.SZ)公告称，公司收到飞利浦(中国)投资有限公司 出具的《告知函》，飞利浦于2025年9月25日至2025年10月10日通过集中竞价及大宗交易方式合计减持 公司股份约1579万股，占公司总股本1.019528%，所持公司股份比例从9.999996%下降至8.977366%。本 次权益变动不会导致公司控制权发生变更，不会对公司治理结构及持续经营产生重大影响。 ...

Core Viewpoint - The company, Chuangye Huikang (300451.SZ), announced that Philips (China) Investment Co., Ltd. will reduce its shareholding in the company from 9.999996% to 8.977366% through centralized bidding and block trading, totaling 15.79 million shares, which will not affect the company's control or governance structure [1] Summary by Relevant Sections - **Shareholding Change** - Philips will reduce its stake in Chuangye Huikang by 15.79 million shares, decreasing its ownership percentage from 9.999996% to 8.977366% [1] - The total shares reduced represent approximately 1.019528% of the company's total share capital [1] - **Impact on Company** - The reduction in shareholding will not lead to a change in control of the company [1] - There will be no significant impact on the company's governance structure or ongoing operations [1]

证券代码：300451 证券简称：创业慧康 公告编号：2025-056 创业慧康科技股份有限公司 | 1.基本情况 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | | 信息披露义务人 | | | 飞利浦（中国）投资有限公司 | | | | | 住所 | | 上海市静安区灵石路718号A1幢 | | | | | | 权益变动时间 | | 2025年10月10日 飞利浦（中国）投资有限公司基于自身战略安排和需求， | | | | | | 权益变动过程 | | 于2025年9月25日至2025年10月10日通过集中竞价及大宗交易 方式合计减持公司股份15,793,764股，所持公司股份比例从 9.999996%下降至8.977366%（注：总股本按剔除公司回购专 用账户中的股份数量4,698,200股后的股数1,544,426,492股计 算，下同），权益变动触及1%的整数倍。 本次权益变动不会导致公司控制权发生变更，不会对公司 | | | | | | 股票简称 | | 治理结构及持续经营产生重大影响。 创业慧康 300451 | 股票代码 | | ...

Core Viewpoint - The company, Chuangshihui Kang (300451.SZ), focuses on the field of healthcare information technology, emphasizing smart healthcare, regional health, and healthy cities as its core development directions [1] Company Focus - The company is currently not involved in smart government services [1]

Core Viewpoint - The company, Chuangshihui Kang (300451.SZ), remains focused on the field of healthcare information technology, emphasizing smart healthcare, regional health, and healthy cities as its core development directions [1] Company Focus - The company does not currently engage in smart government business [1]

Core Viewpoint - The company is focused on deepening its presence in the domestic healthcare information market, prioritizing service quality and meeting domestic demand, while not expanding its business in the U.S. at this stage [1] Group 1 - The company is committed to enhancing service quality in the domestic healthcare information sector [1] - The primary task for the company is to meet domestic demand [1] - Currently, the company has not expanded its business operations in the United States [1]

Group 1 - The core transaction involved 1.95 million shares of Chuangye Huikang, with a total transaction value of 7.761 million yuan, accounting for 5.58% of the total trading volume on that day [1] - The transaction price was 3.98 yuan per share, representing a discount of 14.96% compared to the market closing price of 4.68 yuan [1][2] - The buyer was an institutional investor, specifically the Institutional Special Account, while the seller was China International Capital Corporation Limited, Shanghai Branch [2]